SCHEMBL18597892

SCHEMBL18597892

CCOC(=O)C(CO)C[C@H](N)Cc1ccc(-c2ccccc2F)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 11/20 0.48
▸ PPARG P37231 2/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ GPR88 Q9GZN0 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA5B Q9Y2D0 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890510 1.00 MME (0.48) MMEPPARGPPARAALDH1A1MAPT
SCHEMBL18386378 0.91 MME (0.43) MMEPPARGPPARAALDH1A1MAPT
SCHEMBL18597988 0.87 PPARG (0.46) MMEPPARGPPARAALDH1A1MAPT
SCHEMBL14919221 0.87 MME (0.52) MMEPPARGPPARAGPR88MEN1
SCHEMBL11969895 0.87 MME (0.52) MMEPPARGPPARAGPR88MEN1
SCHEMBL16939261 0.86 MME (0.55) MME
SCHEMBL16939264 0.82 MME (0.69) MMEPPARGGPR88CA12CA1
SCHEMBL11969564 0.82 MME (0.69) MMEPPARGGPR88CA12CA1
SCHEMBL20371160 0.82 MME (0.51) MMEPPARGPPARANPSR1
SCHEMBL20376371 0.79 MME (0.42) MMEPPARGPPARACA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-B1 OXALIC ACID AMIDES AS NEPRILYSIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND PREPARATION THEREOF THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-03-08 — — EP disclosed
Send feedback